DAFNA Capital Management as of June 30, 2025
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 76 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Etf (XBI) | 9.5 | $35M | 416k | 82.93 | |
| Stereotaxis Com New (STXS) | 8.0 | $29M | 14M | 2.12 | |
| Revolution Medicines (RVMD) | 6.9 | $25M | 677k | 36.79 | |
| Blueprint Medicines (BPMC) | 6.0 | $22M | 169k | 128.18 | |
| Merus N V (MRUS) | 5.8 | $21M | 399k | 52.60 | |
| AtriCure (ATRC) | 5.4 | $19M | 592k | 32.77 | |
| Cytokinetics Com New (CYTK) | 3.6 | $13M | 398k | 33.04 | |
| Ideaya Biosciences (IDYA) | 3.6 | $13M | 619k | 21.02 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 3.6 | $13M | 103k | 126.51 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.5 | $13M | 73k | 172.60 | |
| Xenon Pharmaceuticals (XENE) | 2.5 | $9.0M | 288k | 31.30 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $8.9M | 71k | 125.69 | |
| Axogen (AXGN) | 2.2 | $8.0M | 742k | 10.85 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $6.6M | 582k | 11.30 | |
| Dex (DXCM) | 1.6 | $5.7M | 66k | 87.29 | |
| Day One Biopharmaceuticals I (DAWN) | 1.6 | $5.7M | 879k | 6.50 | |
| Stoke Therapeutics (STOK) | 1.6 | $5.7M | 502k | 11.35 | |
| Tandem Diabetes Care Com New (TNDM) | 1.5 | $5.5M | 294k | 18.64 | |
| Arcus Biosciences Incorporated (RCUS) | 1.4 | $5.1M | 628k | 8.14 | |
| Syndax Pharmaceuticals (SNDX) | 1.4 | $5.1M | 544k | 9.37 | |
| Mineralys Therapeutics (MLYS) | 1.4 | $5.0M | 372k | 13.53 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.4 | $5.0M | 4.0M | 1.25 | |
| Urogen Pharma (URGN) | 1.3 | $4.8M | 350k | 13.70 | |
| Inogen (INGN) | 1.2 | $4.3M | 606k | 7.03 | |
| Galapagos Nv Spon Adr (GLPG) | 1.0 | $3.6M | 130k | 27.99 | |
| Biohaven (BHVN) | 0.9 | $3.3M | 235k | 14.11 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.9 | $3.2M | 1.6M | 2.04 | |
| Edgewise Therapeutics (EWTX) | 0.9 | $3.1M | 238k | 13.11 | |
| Insulet Corporation (PODD) | 0.9 | $3.1M | 9.9k | 314.18 | |
| Immunovant (IMVT) | 0.8 | $3.1M | 192k | 16.00 | |
| Alkermes SHS (ALKS) | 0.8 | $3.0M | 104k | 28.61 | |
| Bicara Therapeutics (BCAX) | 0.8 | $2.9M | 317k | 9.29 | |
| Tela Bio (TELA) | 0.8 | $2.8M | 1.4M | 1.94 | |
| Kura Oncology (KURA) | 0.7 | $2.7M | 463k | 5.77 | |
| Denali Therapeutics (DNLI) | 0.7 | $2.4M | 169k | 13.99 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.6 | $2.3M | 811k | 2.80 | |
| Align Technology (ALGN) | 0.6 | $2.1M | 11k | 189.33 | |
| BioCryst Pharmaceuticals (BCRX) | 0.5 | $2.0M | 218k | 8.96 | |
| Astria Therapeutics (ATXS) | 0.5 | $1.7M | 325k | 5.36 | |
| Keros Therapeutics (KROS) | 0.5 | $1.7M | 130k | 13.35 | |
| Viking Therapeutics (VKTX) | 0.5 | $1.7M | 65k | 26.50 | |
| Accuray Incorporated (ARAY) | 0.5 | $1.7M | 1.2M | 1.37 | |
| Brainsway Sponsored Ads (BWAY) | 0.5 | $1.7M | 127k | 13.15 | |
| Allogene Therapeutics (ALLO) | 0.4 | $1.6M | 1.4M | 1.13 | |
| Lexeo Therapeutics (LXEO) | 0.4 | $1.5M | 378k | 4.02 | |
| Foghorn Therapeutics (FHTX) | 0.4 | $1.4M | 301k | 4.70 | |
| Iteos Therapeutics | 0.4 | $1.4M | 141k | 9.97 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $1.4M | 135k | 10.15 | |
| Compass Therapeutics (CMPX) | 0.4 | $1.4M | 527k | 2.60 | |
| Immatics Nv SHS (IMTX) | 0.4 | $1.3M | 245k | 5.38 | |
| Alector (ALEC) | 0.4 | $1.3M | 913k | 1.40 | |
| Mediwound Shs New (MDWD) | 0.3 | $1.2M | 65k | 19.37 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.3 | $1.2M | 59k | 20.74 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $1.2M | 471k | 2.48 | |
| Larimar Therapeutics (LRMR) | 0.3 | $1.1M | 371k | 2.89 | |
| Vyne Therapeutics (VYNE) | 0.3 | $1.0M | 636k | 1.65 | |
| Gossamer Bio (GOSS) | 0.3 | $1.0M | 850k | 1.23 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.3 | $977k | 43k | 22.54 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $970k | 426k | 2.28 | |
| Century Therapeutics (IPSC) | 0.3 | $952k | 1.7M | 0.56 | |
| Neurogene (NGNE) | 0.2 | $764k | 51k | 14.95 | |
| Biontech Se Sponsored Ads (BNTX) | 0.2 | $745k | 7.0k | 106.47 | |
| Polypid (PYPD) | 0.2 | $734k | 208k | 3.53 | |
| Korro Bio (KRRO) | 0.2 | $721k | 58k | 12.49 | |
| Compugen Ord (CGEN) | 0.1 | $485k | 272k | 1.78 | |
| Aquestive Therapeutics (AQST) | 0.1 | $470k | 142k | 3.31 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $448k | 65k | 6.95 | |
| Erasca (ERAS) | 0.1 | $445k | 350k | 1.27 | |
| Adicet Bio (ACET) | 0.1 | $329k | 540k | 0.61 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $327k | 122k | 2.68 | |
| Sutro Biopharma (STRO) | 0.1 | $312k | 437k | 0.71 | |
| Nektar Therapeutics Com New (NKTR) | 0.1 | $258k | 10k | 25.84 | |
| Aprea Therapeutics Com New (APRE) | 0.1 | $232k | 137k | 1.69 | |
| Biomx Com New (PHGE) | 0.0 | $181k | 401k | 0.45 | |
| Procept Biorobotics Corp (PRCT) | 0.0 | $173k | 3.0k | 57.60 | |
| Inflarx Nv (IFRX) | 0.0 | $158k | 200k | 0.79 |